These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 25333683

  • 1. Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
    Berge C, Courand PY, Harbaoui B, Paget V, Khettab F, Bricca G, Fauvel JP, Lantelme P.
    J Hypertens; 2015 Jan; 33(1):118-25. PubMed ID: 25333683
    [Abstract] [Full Text] [Related]

  • 2. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Semplicini A, Agabiti-Rosei E, Pessina AC, Mantero F, PAPY Study Investigators.
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [Abstract] [Full Text] [Related]

  • 3. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [Abstract] [Full Text] [Related]

  • 4. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
    Kater CE, Biglieri EG.
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z, Widimský J, Rosa J, Wichterle D, Strauch B, Petrák O, Zelinka T, Vlková J, Masek M, Dvoráková J, Holaj R.
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
    Sergev O, Rácz K, Varga I, Kiss R, Fütö L, Gutkowska J, Gláz E.
    Clin Exp Hypertens A; 1991 Oct; 13(3):409-23. PubMed ID: 1832596
    [Abstract] [Full Text] [Related]

  • 9. [Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
    Zuo FJ, Zhou XH, Ren Y, Chen T, Tian HM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):298-303. PubMed ID: 32543133
    [Abstract] [Full Text] [Related]

  • 10. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
    Okamoto R, Taniguchi M, Onishi Y, Kumagai N, Uraki J, Fujimoto N, Fujii E, Yano Y, Ogura T, Ito M.
    Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
    [Abstract] [Full Text] [Related]

  • 11. [Does the captopril test improve the diagnosis of primary hyperaldosteronism?].
    Wambach G, Degenhardt S, Bönner G, Stimpel M, Grimm U, Krone W.
    Dtsch Med Wochenschr; 1992 Jul 31; 117(31-32):1175-80. PubMed ID: 1644014
    [Abstract] [Full Text] [Related]

  • 12. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
    Mantero F, Fallo F, Opocher G, Armanini D, Boscaro M, Scaroni C.
    Clin Sci (Lond); 1981 Dec 31; 61 Suppl 7():289s-293s. PubMed ID: 7032817
    [Abstract] [Full Text] [Related]

  • 13. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M.
    J Hypertens; 2007 Jan 31; 25(1):177-86. PubMed ID: 17143190
    [Abstract] [Full Text] [Related]

  • 14. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
    Matsumoto T, Oki K, Kajikawa M, Nakashima A, Maruhashi T, Iwamoto Y, Iwamoto A, Oda N, Hidaka T, Kihara Y, Kohno N, Chayama K, Goto C, Aibara Y, Noma K, Liao JK, Higashi Y.
    Hypertension; 2015 Apr 31; 65(4):841-8. PubMed ID: 25624340
    [Abstract] [Full Text] [Related]

  • 15. The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma.
    Rossi GP, Barisa M, Belfiore A, Desideri G, Ferri C, Letizia C, Maccario M, Morganti A, Palumbo G, Patalano A, Roman E, Seccia TM, Pessina AC, Mantero F, PAPY study Investigators.
    J Hypertens; 2010 Sep 31; 28(9):1892-9. PubMed ID: 20683340
    [Abstract] [Full Text] [Related]

  • 16. [Analysis of characteristics of renin, aldosterone and aldosterone/renin ratio in patients with aldosterone-producing adenoma].
    He YB, Yu X, Zhou XR, Shu BH, Liu JH.
    Zhonghua Yi Xue Za Zhi; 2013 Nov 12; 93(42):3379-83. PubMed ID: 24418036
    [Abstract] [Full Text] [Related]

  • 17. Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions.
    Vorselaars WMCM, Valk GD, Vriens MR, Westerink J, Spiering W.
    J Hypertens; 2018 Jul 12; 36(7):1585-1591. PubMed ID: 29528872
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
    Rossitto G, Regolisti G, Rossi E, Negro A, Nicoli D, Casali B, Toniato A, Caroccia B, Seccia TM, Walther T, Rossi GP.
    Hypertension; 2013 Feb 12; 61(2):526-33. PubMed ID: 23248149
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.